Clinical trial
Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut
NCT03013517 is registered in ClinicalTrials.gov with DBV Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut
- Lead sponsor
- DBV Technologies
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 23, 2017
- Completion date
- March 31, 2023
- Enrollment
- 300 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.
peanut allergy